RxDoctor Payments Data

Amy Kulak, MD

Ophthalmic Plastic and Reconstructive Surgery · Jacksonville Beach, FLNPI 1689823783

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Lumenis BE Inc at 31.3% of the total. Reporting peaked in 2024 at $1,880 and has fallen 62.0% since, to $715 in 2025.

$4,220in general payments, 2019–2025

Across 89 payments — averaging $47.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$1K
  • Amgen$981
  • AbbVie$576
  • Tarsus Pharmaceuticals, Inc.$246
  • Revance Therapeutics, Inc.$236
  • Sight Sciences, Inc.$205
  • plus $655 from 12 others

What the payments were for

  • Food & beverage$4,220100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,220 in reported general payments places this provider in the 65th percentile of 37 ophthalmic plastic and reconstructive surgery providers in Florida.

See all ophthalmic plastic and reconstructive surgery providers in Florida

Medicare billing

Part B allowed, 2024
$184,868
Medicare patients
352
Services billed
1,844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha157$1,452
Doxycycline Hyclate18$518
ErythromycinErythromycin Base52$510
Ondansetron OdtOndansetron123$427
ValacyclovirValacyclovir Hcl15$177
MoxifloxacinMoxifloxacin Hcl15$160
Cephalexin26$142
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$105

Paid to pharmacies, not to this prescriber.

Other ophthalmic plastic and reconstructive surgery in Jacksonville Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →